Research News - August 13, 2021

         
 
August 13, 2021
ANNOUNCEMENTS
 

1. The 2021 MGRI Image Awards have begun!
2. Learn Something New! Series
3. Employee COVID-19 Vaccine Requirements and Deadlines
4. Annual ECOR Elections – Nominations are Open!
5. Invitation to Submit Nominations for the Mary "Kay" Ryan Award for Excellence in Support of Clinical Research at MGH

EVENTS
 

1. Learn Something New! Series
2. Informed Consent Including eConsent
3. Fun Friday: The Practice of Journaling in the Moment
4. Two Meditation Sessions available every week
5. QI Bootcamp for Clinical Researchers and Study Staff
6. Virtual Visits
7. Design and Conduct of Clinical Trials
8. MGH will celebrate the 19th Annual Clinical Research Day
9. 2021 Virtual Tumor Course

FUNDING OPPORTUNITIES
 

1. COVID Funding Opportunities
2. Harrington Prize for Innovation in Medicine *LAST CHANCE TO APPLY!*
3. NIH Research Supplements to Promote Diversity in Health-Related Research
4. The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care & The Ki Sub Joung Innovative Early Career Faculty Pilot Award in Aging and Palliative Care 2021
5. Job Research Foundation Announces 4th Round of Funding
6. NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities
7. T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592
8. Limited Submission Funding Opportunities
9. Foundation Funding Opportunities

In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events
 
ANNOUNCEMENTS
 
1. The 2021 MGRI Image Awards have begun!

The Mass General Research Institute (MGRI) Image Contest was created in 2018 to showcase the breadth of research occurring across Massachusetts General Hospital. We receive so many great images each year that it’s become increasingly difficult to select one winner. So this year, we’re proud to reimagine the MGRI Image Contest into the MGRI Image Awards.

With the new name comes new categories and more opportunities to highlight the many faces of research at Mass General. Learn more about the 2021 Awards on Bench Press and enter now through September 24! massgeneral.link/2021-image-awards

 
2. Learn Something New! Series

Click here for a full list of topics and dates

Clinical research is complicated. It is governed by regulations, guidelines, and institutional policies. It involves people inside and outside of the institution, in clinical areas, doing financial management, etc. But you don’t have to do it all on your own! Join the DCR’s network of study coordinators, research assistance, and project managers to learn something new about different clinical research operations topics. With something for everyone, these sessions cover how to’s on protocols, basic study designs, informed consent, managing your day to day, and many more. To get the most out of this program, you should have already completed the CITI Training in Human Subjects Research and Clinical Research Conduct: Research Staff Training prior to enrolling. It is also recommended that you take Good Clinical Practice in an Academic Research Institution prior to enrolling. Contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more.
 
3. Employee COVID-19 Vaccine Requirements and Deadlines

As Mass General Brigham President and CEO Anne Klibanski, MD, previously communicated, the pandemic’s changing landscape — particularly, the rise of the highly transmissible Delta variant — has required us to reevaluate the timing of our COVID-19 vaccination requirement for staff.
Vaccination remains our best defense against this virus. The available vaccines are safe and effective at preventing serious illness and death from COVID-19. As health care workers, we all have a responsibility to protect not only the vulnerable populations we care for but also ourselves and our colleagues.
To ensure the safety of our patients, their loved ones and our workforce, all MGH staff must be fully vaccinated and document their vaccination status by Friday, October 15, 2021 (meaning that you must receive both doses of Pfizer or Moderna, or a single dose of Johnson & Johnson, by this date). This is a condition of employment. Failure to meet this deadline will result in loss of Epic/computer access, unpaid administrative leave and, if noncompliance continues, termination of employment.
The following provides a quick summary of key deadlines. Please see below for further details about each of these items.

  • September 3 – Medical and/or religious exemption requests
  • September 13 - Clearance for new hires
    • Actions required: New hires who have their Occupational Health visit starting on September 13 must have their COVID-19 vaccination status validated by Occupational Health to begin work.
  • September 16 - If unvaccinated: Deadline for first dose of Moderna vaccine
    • Actions required: Receive the vaccine and, for non-Mass General Brigham sites, obtain proof of vaccination.
  • September 23 - If unvaccinated: Deadline for first dose of Pfizer vaccine
    • Actions required: Receive the vaccine and, for non-Mass General Brigham sites, obtain proof of vaccination.
  • October 13 - COVID-19 vaccination deadline
    • Actions required: Complete your full COVID-19 vaccination series (i.e., receive either two doses of Pfizer/Moderna or one dose of Johnson & Johnson).  After vaccination, you need to report and document your vaccination status. It is not done automatically.

How can I get the COVID-19 vaccine?

  • Appointments are available on the main campus. Schedule an appointment in COVID Pass or call Occupational Health Services (OHS) at 617-732-6034.
  • Schedule an appointment at a community-based vaccine clinic at locations across Massachusetts . These clinics offer free vaccines at convenient hours, including evenings and weekends.

I already got my COVID-19 vaccine. Do I need to do anything else?
Yes. Similar to our seasonal flu shot program, our COVID-19 vaccination program requires all staff to provide proof of vaccination to Occupational Health. Your vaccine status is not shared automatically, even if you received your vaccine at an MGB location.
Before October 15, 2021 you must document your COVID-19 vaccine by doing one of the following:

  • If you received your vaccine at a Mass General Brigham clinic, please complete this survey to consent to share your vaccination record with Occupational Health. Log in using your Mass General Brigham login and password and select MGB Sponsored Vaccine Clinic to navigate to the consent question.
  • If you received your vaccine anywhere outside of Mass General Brigham (such as a retail pharmacy), complete this survey to record and upload your vaccine documentation. Log in using your Mass General Brigham login and password and select Non-MGB Vaccine Clinic or Outside Provider to submit your documentation.

Can I be exempted from the vaccine requirement?
Staff seeking an exemption from the COVID-19 vaccine requirement for medical or religious reasons must submit an exemption request. The deadline for this is Friday, September 3, 2021.

  • The medical exemption form can be downloaded here. This form must be completed and signed by your health care provider.
  • The religious exemption request form can be accessed here.


What happens if I wait until October 15 to get the COVID-19 vaccine?
Unless you obtain the single-dose Johnson & Johnson vaccine, you will not be able to meet the deadline.  To meet the October 15 deadline with a Pfizer or Moderna vaccine, employees must receive their first dose by the following dates:

  • Moderna: Thursday, September 16, 2021
  • Pfizer: Thursday, September 23, 2021

What about new hires?
Starting September 13, 2021 all new hires who have their Occupational Health visit on or after this date must have their COVID-19 vaccine status validated by Occupational Health before they can receive clearance to start work.

New hires can present documentation of either a first dose or both doses (Pfizer/Moderna) or single dose (Johnson & Johnson). New hires who have only received their first dose of Pfizer or Moderna by the time of their Occupational Health visit will receive temporary clearance and must follow-up with Occupational Health after receiving their second dose for final clearance.

I have another question not addressed here.
Answers to other frequently asked questions are available on Pulse.

 
4. Annual ECOR Elections – Nominations are Open!

Nominate Yourself or a Colleague!

ECOR representatives should be able to speak to the interests and concerns of their colleagues (fellow MGH faculty members) in discussions and planning for research at MGH.  To learn more about ECOR or the responsibilities of an  Elected Representative to ECOR, please visit click here

Nominations Deadline: Wednesday, September 22, 2021

- TWO OPENINGS -
One Assistant Professor
One Professor

Who is eligible to nominate?
All MGH faculty with an academic rank of Assistant, Associate, or Full Professor, and who are primarily researchers, are eligible to nominate.

Nomination form: https://ecor.mgh.harvard.edu/elections/NominationForm.aspx

Questions? ECOR@mgh.harvard.edu

 
5. Invitation to Submit Nominations for the Mary "Kay" Ryan Award for Excellence in Support of Clinical Research at MGH

This award was established in 2017 to commemorate May “Kay” Ryan, a dedicated member of the MGH Clinical Research community. Kay, as she was known to her colleagues, is remembered for her devotion to helping Clinical Research Investigators and Study Staff. She selflessly did her work under the radar while making MGH great. All MGH Clinical Research Staff (study coordinators, research assistants, program/project managers, research nurses and research administrators) are eligible for nomination. Anyone may provide a nomination - supervisor, co-worker or colleague.

Please, submit nominations here by September 1, 2021.

If you have any questions, please contact Tiereny Morrison-Rohlfs.

Click here to learn more about the Mary “Kay” Ryan Award for Excellence in Support of Clinical Research at MGH.

 
Back to top
EVENTS
 
1. Learn Something New! Series

July – September, 11:00 AM – 12:00 PM, Zoom

Click here for a full list of topics

Clinical research is complicated. It is governed by regulations, guidelines, and institutional policies. It involves people inside and outside of the institution, in clinical areas, doing financial management, etc. But you don’t have to do it all on your own! Join the DCR’s network of study coordinators, research assistants, and project managers to learn something new about different clinical research operations topics. With something for everyone, these sessions cover how to’s on protocols, basic study designs, informed consent, managing your day to day, and many more.

To get the most out of this program, you should have already completed the CITI Training in Human Subjects Research and Clinical Research Conduct: Research Staff Training prior to enrolling. It is also recommended that you take Good Clinical Practice in an Academic Research Institution prior to enrolling.

Please browse a full list of topics here and register for each individually.

Please contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more.

 
2. Informed Consent Including eConsent

Friday, August 13, 2021, 10:00 – 11:30 AM, Zoom

Speaker: Pamela Richtmyer, Director, Partners Human Research Quality Improvement Program
This course is intended for investigators and research staff.  In addition to covering the required elements of the informed consent, this course will address the following:

  • Different options available for obtaining consent
  • Tips for writing an effective consent  
  • Documentation required for obtaining consent
  • ICF Recordkeeping   
  • Special Considerations

Register here.

Please contact Tiereny Morrison-Rohlfs with questions. Click here to learn more.

 
3.  Fun Friday: The Practice of Journaling in the Moment

Friday, August 13, 2021, 12:00 – 1:00 PM, Zoom
Sponsored by the Center for Faculty Development’s Office for Well-Being

Fun Fridays offer a refreshing mid-day break from work to indulge in physical, mental, or creative activity.

Journaling is a creative outlet that can help us appreciate the little things in life and stay present in the moment. Join Olga as she provides an overview of the benefits of daily writing, shows how to start, and shares best journaling practices. Join us! Set the mood by finding a quiet place to relax. Bring paper, pen or pencil, or have a blank document handy on your electronic device.

Instructor: Olga Katsovskiy, MHA, is an Office/Program Manager in the Endocrine Unit at MGH. She has a BS in Creative Writing and is devoted to good coffee and daily journaling. 

Register and receive link
 
4. Two Meditation Sessions available every week

Monday, August 16, 2021 & Wednesday, 18, 2021, 8:00 – 8:30 AM, Zoom

SESSION 1: Meditation Mondays with Dr. Darshan Mehta 
Every Monday, 8:00 – 8:30 am, Zoom à next session, Monday, August 16!
Co-sponsored by the Center for Faculty Development’s Office for Well-Being and the MGPO Frigoletto Committee

Join Darshan Mehta, MD, MPH, Director, Office for Well-Being for a guided meditation session on Monday mornings. 
Attend sessions via Zoom

SESSION 2: Midweek Meditation with Guest Leader 
Every Wednesday, 8:00 – 8:30 am, Zoom à next session, Wednesday, August 18!
Sponsored by the Center for Faculty Development’s Office for Well-Being

Join guest leader, Sara Lazar, PhD, Department of Psychiatry, for next Wednesday’s guided meditation session on August 18th!
Attend sessions via Zoom

If you would like to receive an Outlook invitation for these sessions, email owb@partners.org

 
5. QI Bootcamp for Clinical Researchers and Study Staff

Monday, August 16, 2021, 10:00 AM -12:30 PM, Zoom

Speaker: Pamela Richtmyer, Director, Human Research Affairs Compliance and Education Office

The QI Program Clinical Research Bootcamp is a “clinical research 101” for study staff and investigators. The course is not only an introduction to clinical research for new investigators and study staff but also good review for experienced study teams.  Many teams include this course as part of the onboarding process for new study staff.  The course covers research regulations, GCP guidelines, and institutional policies relevant to the day to day conduct of clinical research.  Topics include:

  • Informed Consent documentation
  • Study Documentation (subject files, source documents, and data collection forms)
  • Unanticipated Problems, Deviations and Violations
  • Investigational Product Management and Accountability
  • Regulatory Binder and Essential Documents
  • ClinicalTrials.Gov
  • Inspections and audits 
  • Other relevant topics

*This course is worth 2 RCR Credits.

Register here. Please contact  Tiereny Morrison-Rohlfs with any questions.

Click here to learn more.

 
6. Virtual Visits

Wednesday, August 18, 2021, 1:00 – 2:30 PM, Zoom

Speaker: Pamela Richtmyer, Director, Partners Human Research Quality Improvement Program

The Virtual Clinical Research Visits course will discuss best practices and special considerations for remote clinical research study visits including obtaining consent.  We will also discuss documentation and training requirements as well as recently released FDA requirements for remote visits. 

Register here. Please contact Tiereny Morrison-Rohlfs with questions.

Click here to learn more.
 
7. Design and Conduct of Clinical Trials

Tuesdays and Thursdays: September 02 – November 09, 2021, 5:00 – 6:30pm

Sponsored by the MGH Division of Clinical Research, the Division of Infectious Diseases, and the Department of Psychiatry

Applications due August 23, 2021

Design and Conduct of Clinical Trials is an intensive thirteen-session course offered from early-September through late October. Physicians with a serious interest in clinical trials will be introduced to theoretical and practical issues facing clinical researchers.  Course participants will learn how to envision, plan, develop and execute effective clinical trials. Study content includes research designs, protocols, ethical patient recruitment, informed consent, regulations, and clinical trial management.

The course is ideally suited for clinical fellows starting their research years, junior faculty pursuing careers in clinical research, and physicians with an interest in becoming more actively involved in clinical research.  All participants are expected to use the course curriculum to develop and present a trial design at the final session of the course. 

Enrollment is limited to facilitate interaction and individual attention. To ensure placement in the course, early application is recommended. All applications will be reviewed after the August 23rd deadline.
To submit an application and/or view a course schedule, please go to: Design and Conduct of Clinical Trials. *This site is not compatible with Internet Explorer, please use Chrome or Edge

Please contact Teresa La with any questions.

 
8. MGH will celebrate the 19th Annual Clinical Research Day

Thursday, October 14, 2021, 8:00 AM – 12:00 PM

To learn more about MGH Clinical Research Day 2021 please visit the portal.

 
9. 2021 Virtual Tumor Course

Monday, November 2, 2021 – Thursday, November 4, 2021

36TH Critical Issues in Tumor Microenvironment Angiogenesis, Metastasis and Immunology

For comprehensive information about this course, including faculty, schedule, and pricing,
please visit the 36th Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology website
The “36th Annual Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology” course, directed by Professor Rakesh K. Jain, will continue to offer the best in critical analysis of what is currently known about the tumor microenvironment, angiogenesis, metastasis, immunology, metabolism and chronobiology. This will include chimeric antigen receptor (CAR) T-cell therapies and the role of microbiome as newly introduced topics this year. The faculty is internationally recognized. They will present their latest findings from their clinics and laboratories. The goal is to highlight key gaps in present knowledge of cancer and outline future directions for research at the bench, in the clinic, and in drug development.

The course will continue its four-day online webinar-based live lecture format. Learning formats will include didactic lectures, Q&A and group discussions. The faculty will encourage an open discussion and will provide critical comments on challenges and future opportunities in research in cancer and in establishment of novel therapy approaches and biomarkers to guide treatment. The aim of this course is to analyze and synthesize the most up-to-date findings. Our faculty will present valuable information in a systematic and comprehensive framework, along with a critical review of various measurement techniques. This course is dedicated to helping to improve clinical translation of this knowledge and competence, leading to improved cancer treatment.  

Harvard Medical School’s secure online registration.

Click here to for an overview 

Click here to view the brochure

 
Back to top
FUNDING OPPORTUNITIES
 
1. COVID Funding Opportunities

Please visit the new MGB web page for COVID funding opportunities that provides a central database for researchers to view open and competitive funding announcements.

We have aggregated opportunities from federal and private funding sources including NIH, DoD, CDC, EPA, foundations, and more.  The database defaults to sorting by award amount and can also be sorted by deadline or filtered by research focus.

Upcoming deadlines:

  • No upcoming deadlines

Recently added:

  • No recently added opportunities
 
2. Harrington Prize for Innovation in Medicine *LAST CHANCE TO APPLY!*

The Harrington Prize for Innovation in Medicine, presented by the American Society for Clinical Investigation and the Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development – honors a physician-scientist who has moved science forward with notable achievements in innovation, creativity and potential for clinical application.
This annual prize includes:

  • An unrestricted $20,000 honorarium
  • The Harrington Prize Lecture, delivered at the 2022 AAP/ASCI/APSA Joint Meeting
  • Participation at the 2022 Harrington Discovery Institute Symposium
  • A personal essay, published in the Journal of Clinical Investigation

This prize requires an institutional nomination. MGH is not limited in the number of nominees we can submit. If you are interested, please contact MGH ECOR at ecor@partners.org by September 1, 2021 to be considered.

 
3.  NIH Research Supplements to Promote Diversity in Health-Related Research

Fostering diversity in the scientific research workforce is a key component of the NIH strategy to identify, develop, support and maintain the quality of our scientific human capital NOT-OD-20-031.

This administrative supplement is designed to provide support for research experiences for individuals from diverse backgrounds throughout the continuum from high school to the faculty level. Continuation of this program in the future will depend on the evaluation of the career outcomes of the supported individuals as well as continuing assessments of the diversity of the scientific workforce.

Please click here to learn more.

 
4. The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care & The Ki Sub Joung Innovative Early Career Faculty Pilot Award in Aging and Palliative Care 2021

Applications are now being accepted by the Mongan Institute Center for Aging and Serious Illness for the The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care & The Ki Sub Joung Innovative Early Career Faculty Pilot Award in Aging and Palliative Care

What is it?
The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care & The Ki Sub Joung Innovative Junior Faculty Pilot Award in Aging and Palliative Care will support innovative applied clinical research or implementation pilot project(s) (T3-4) focused on improving the evidence base for aging or serious illness care. This RFA will fund initial pilot work to provide data and planning for an externally funded, full-scale project grant (e.g. K award, R01, PCORI etc.). Applicants who hold a full-time appointment in any MGH Department, are pursuing a research career, and meet the eligibility criteria below are encouraged to apply.

The Chong Jin Park Innovative Early Career Pilot Award in Aging and Palliative Care will support research focused on achieving health equity and improving the lives of older people and or those with serious illness through research in population and health care delivery science.

The Ki Sub Joung Innovative Early Career Faculty Pilot Award in Aging and Palliative Care will support research focused on improving the lives of older people and or those with serious illness, with an emphasis on the care of those living with cognitive impairment or their caregivers.

How much is the award?
The award is $50,000 for one year plus 15% indirect costs and is effective October 1, 2021.  

When is the deadline?
August 16, 2021 by 5 pm EDT

How do I learn more and apply?

 
5. Job Research Foundation Announces 4th Round of Funding

$400,000 in Grants Available to Researchers Investigating Causes/Treatments of Rare Multisystem Immunodeficiency Disorder

The Job Research Foundation, which seeks to help find a cure for Job Syndrome by providing the global scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, has announced the fourth round of grant funding. The Foundation will award two two-year grants in the amount of $200,000 each to scientific researchers who are investigating the causes of, and treatments for, Job Syndrome. Grant applications can be found online at https://www.jobresearchfoundation.org/grant-proposal-application . Deadline to apply is October 15, 2021.

The long-term goal of the Foundation is to help advance research to find a cure for Job Syndrome. In the short term, the Foundation hopes the research will improve the treatments for patients suffering from the rare disorder.

To date the organization has funded a total of ten research projects across the world. In 2019, Job Research Foundation awarded four grants in the first round of funding to researchers from Australia, Spain, Germany, and the United States. In 2020, four grants were awarded to researchers in the United States and the United Kingdom in the second round of funding. This year’s recipients are based in the United States and in Germany.

Special consideration will be given to research focused on Job Syndrome and Pulmonary Function. Previous applicants can apply in subsequent years to extend their research. The application process is open to researchers world-wide and awardees will be announced between December 2021 and January 2022.

The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments to help those suffering with Job Syndrome. Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. Visit https://www.jobresearchfoundation.org/ for additional details.

 
6.  NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities

The National Institute of Neurological Disorders and Stroke seeks to promote diversity in all of its research programs and to increase the participation of underrepresented groups. As the US population becomes increasingly diverse, reflection of that diversity among the biomedical research workforce is vital to our science enterprise and the NIH research mission (See NOT-OD-20-031). NIH is committed to implementing approaches to address the funding gap for researchers from diverse backgrounds and “committed to instituting new ways to support diversity, equity, and inclusion, and identifying and dismantling any policies and practices that may harm our workforce and our science”.

This NOSI utilizes the NIH parent R01 announcement to encourage Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) from diverse backgrounds to conduct and contribute to the research areas of the NINDS.

This notice applies to due dates on or after June 5, 2021 and subsequent receipt dates through May 8, 2023. 

Click here to learn more.

 
7. T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592

The primary mission of this program is to promote the development of a diverse, translational research workforce that is capable of participating and/or leading cross-disciplinary team science relevant for the treatment and prevention of Alzheimer’s disease and AD-related dementias.  The trainee will pursue a targeted research project under the mentorship of world-class researchers in the Harvard research community in three key areas:

  1. biology of aging and neurodegeneration;
  2. data sciences, computational biology, statistics, math/engineering/physics;
  3. drug discovery and development

Most T32 faculty are within the MGH Martinos Center for Biomedical Imaging and/or Massachusetts Alzheimer’s Disease Research Center.  Training includes targeted coursework, didactic lectures, and a dedicated T32 lecture series. General training includes research conduct, diversity and inclusion, mentoring, career development, and grant development activities.

Eligibility: PhD, MD, MD/PhD and U.S. citizen or permanent resident (see NIH PAR-18-524), with rolling admission for 4 training slots.  Our goal is to recruit a truly diverse T32 trainee pool that is highly representative of URM and women trainees.

Additional information: Please see  https://pricelab.martinos.org/t32-adrd/ for further information including application instructionsPlease submit questions to:  Krystal Whitfield (T32 Administrative Contact) at T32ADRD@mgh.harvard.edu

 
8. Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process            
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award

If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities                                                                                                                                        
Please click here for more information and for our internal deadlines.

  • Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)
  • Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed) – NEW!
  • Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed) – NEW!

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please let us know at ecor@mgh.harvard.edu.

 
9. Foundation Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities.  Note that proposals are still routed through the standard Insight/Research Management process.

Please be aware that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submitting a proposal.  Training fellowships from foundations, public charity, and non-profit organizations are excluded from this minimum IDC requirement.

Week of 08/13/21

  • Lawrence M. Brass Stroke Research Award, American Brain Foundation (ABF) /American Academy of Neurology (AAN). $150,000. Application Deadline: October 1
  • Research Grants, Bruno and Ilse Frick Foundation for Research on ALS. ≈ $108,00. Application Deadline: September 30
  • Clinic and Laboratory Integration Program (CLIP), Cancer Research Institute (CRI). $200,000. LOI Deadline: November 1
  • Grants, Caplan Foundation for Early Childhood. Unspecified Amount: LOI Deadline: September 30
  • CARRA-Arthritis Foundation Large Grants, Childhood Arthritis and Rheumatology Research Alliance CARRA. $50,000. LOI Deadline: September 1
  • Clinical Pilot and Feasibility Awards, Cystic Fibrosis Foundation (CFF)/Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT). $160,000. LOI Deadline: August 16
  • Clinical Research Award, Cystic Fibrosis Foundation (CFF). $1.05 million. LOI Deadline: August 16
  • Multiple Research Grants, Foundation for Women's Cancer (FWC)/Society of Gynecologic Oncology. $50,000. Abstract Deadline: August 31
  • Charles H. Hood Foundation Child Health Research Awards Program, Health Resources in Action (HRiA)/The Medical Foundation. $165,000. Application Deadline: September 22
  • Cellular Phenotyping in Human iPSCs, The Michael J. Fox Foundation for Parkinson's Research (MJFF) NEW! $1 million. Preliminary Proposal Deadline: September 28
  • MRI Biomarkers: Data Analysis and Tool Generation, The Michael J. Fox Foundation for Parkinson's Research (MJFF). $5 million for total program. Preliminary Proposal Deadline: September 28
  • Parkinson’s Pathway Molecular Data Analysis, The Michael J. Fox Foundation for Parkinson's Research (MJFF) NEW! $350,000. Preliminary Proposal Deadline: September 28
  • Target Advancement Program, The Michael J. Fox Foundation for Parkinson's Research (MJFF). $200,000. Preliminary Proposal Deadline: September 28
  • Therapeutic Pipeline Program: Pre-clinical Program, The Michael J. Fox Foundation for Parkinson's Research (MJFF). $500,000. Preliminary Proposal Deadline: September 28
 
Back to top
In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events

MGH Town Hall Meeting Recordings

MGB Community Connects

Mentor MGB

Check out the Coronavirus Resource Guide for MGH Researchers!

NIH Update for Week Ending August 13, 2021

PCORI - Click here for the latest funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI).

Looking for something you saw in a previous Research News release? Check out our archive!

Back to top
 
RESOURCES  

ECOR Website

Mass General Research Institute

MGH Research Intranet

Research Help and How-To

Your email address is currently listed as:%%emailaddr%%.

Click here to edit your profile or to change your email address for receipt of information about MGH Research.

Click here to subscribe to MGH Research Email announcements.
Executive Committee On Research (ECOR) Massachusetts General Hospital
125 Nashua Street, Suite 822, Boston, MA 02114
ecor@mgh.harvard.edu